Xuan Ma
The Key Laboratory Of Microcosmic Syndrome Differentiation
Kunming, 650500, China
Kunming, 650500, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Nanofibers for organoid cultivation advances from chemical, physical and biological dimensions.
Journal: Colloids and surfaces. B, Biointerfaces
Published: July 07, 2026
Immune crosstalk in metabolic dysfunction-associated steatotic liver disease: interactions between innate and adaptive immunity.
Journal: Frontiers in immunology
Published: March 20, 2026
Electrospinning nanofibers for the treatment of melanoma.
Journal: International journal of pharmaceutics
Published: March 06, 2026
Novel therapeutic strategies targeting mitochondrial quality control for metabolic dysfunction-associated steatotic liver disease.
Journal: Frontiers in physiology
Published: February 03, 2026
Progress in Natural Product Nanocarriers with Drug-excipient Homology.
Journal: Current drug delivery
Published: November 23, 2025
Effect of gentiopicroside on endogenous formaldehyde homocysteine-pathway related proteins in rats with non-alcoholic steatohepatitis.
Journal: Frontiers in pharmacology
Published: September 06, 2025
The action of ginsenoside Rg1 in patients with carotid atherosclerosis: a controlled clinical trial.
The action of ginsenoside Rg1 in patients with carotid atherosclerosis: a controlled clinical trial.
Journal: Frontiers in pharmacology
Published: May 30, 2025
Nickel nanoparticles: a novel platform for cancer-targeted delivery and multimodal therapy.
Journal: Frontiers in drug delivery
Published: May 13, 2025
Mitochondrial Dysfunction as a Pathogenesis and Therapeutic Strategy for Metabolic-Dysfunction-Associated Steatotic Liver Disease.
Journal: International journal of molecular sciences
Published: March 27, 2025
Showing 1-9 of 9
Last Updated: 09/26/2026